Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2000;101:2277-2283

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saino, A.
Right arrow Articles by Mancia, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saino, A.
Right arrow Articles by Mancia, G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Coronary Artery Disease
Hazardous Substances DB
*SODIUM CHLORIDE
Related Collections
Right arrow Autonomic, reflex, and neurohumoral control of circulation
Right arrow Coagulation and fibronolysis
Right arrow Coronary circulation

(Circulation. 2000;101:2277.)
© 2000 American Heart Association, Inc.


Clinical Investigation and Reports

Modulation of Sympathetic Coronary Vasoconstriction by Cardiac Renin-Angiotensin System in Human Coronary Heart Disease

Antonio Saino, MD; Guido Pomidossi, MD; Rodolfo Perondi, MD; Alberto Morganti, MD; Lucia Turolo, PhD; Giuseppe Mancia, MD

From Centro di Fisiologia Clinica e Ipertensione, Università di Milano, Ospedale Maggiore IRCCS, Milan, Italy (A.S., G.P., R.P., A.M., L.T., G.M.); and Clinica Medica, Università di Milano-Bicocca, Ospedale San Gerardo, Monza, Milan (A.S., G.M.).

Correspondence to Prof Giuseppe Mancia, Clinica Medica, Ospedale San Gerardo, Via Donizetti 106, 20052 Monza, Milano, Italy.

Background—In humans, angiotensin II enhances the sympathetic coronary vasoconstriction elicited by the cold pressor test (CPT) and diving. Whether this enhancement depends on the circulating angiotensin II or on the locally produced angiotensin II is unknown, however.

Methods and Results—We addressed this issue in 14 patients with severe coronary artery disease by evaluating the effects of a 2-minute CPT (n=14) and a 30-second dive (n=8) on mean arterial pressure (MAP, arterial catheter), heart rate (ECG), coronary sinus blood flow (CBF, thermodilution technique), and coronary vascular resistance (MAP/CBF ratio). The 2 stimuli were applied at the end of left intracoronary infusion of either saline or benazeprilat diluted at the concentration of 25 µg/mL. The rate of benazeprilat infusion had been preliminarily demonstrated to reduce angiotensin II concentration in the coronary sinus without affecting its arterial concentration. The changes in MAP and heart rate induced by CPT and diving were superimposable during saline and benazeprilat infusions. The decrease in CBF induced by CPT and diving during saline infusion was changed into an increase during benazeprilat infusion with a significant attenuation of the coronary vasoconstrictor response.

Conclusions—In patients with coronary artery disease, an attenuation of sympathetic coronary vasoconstriction can be obtained by reducing cardiac angiotensin II formation without involving circulating angiotensin II. This suggests a role of the tissue renin-angiotensin system in modulating autonomic cardiac drive in humans.


Key Words: circulation • nervous system, sympathetic • renin • angiotensin • coronary disease




This article has been cited by other articles:


Home page
Eur Heart JHome page
R. Jaumdally, C. Varma, R. J. Macfadyen, and G. Y.H. Lip
Coronary sinus blood sampling: an insight into local cardiac pathophysiology and treatment?
Eur. Heart J., April 2, 2007; 28(8): 929 - 940.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J. Herrmann
Peri-procedural myocardial injury: 2005 update
Eur. Heart J., December 1, 2005; 26(23): 2493 - 2519.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. W. Lameris, S. de Zeeuw, D. J. Duncker, G. Alberts, F. Boomsma, P. D. Verdouw, and A. H. van den Meiracker
Exogenous Angiotensin II Does Not Facilitate Norepinephrine Release in the Heart
Hypertension, October 1, 2002; 40(4): 491 - 497.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Prasad, J. P. J. Halcox, M. A. Waclawiw, and A. A. Quyyumi
Angiotensin type 1 receptor antagonism reverses abnormal coronary vasomotion in atherosclerosis
J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1089 - 1095.
[Abstract] [Full Text] [PDF]